Brief: Tango Therapeutics Reports Q1 2023 Financial Results And Provides Business Highlights
09/05/2023 13:22
May 9 (Reuters) - Tango Therapeutics Inc TNGX.O :
* TANGO THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS HIGHLIGHTS
* TANGO THERAPEUTICS INC - AS OF MARCH 31, HELD $333.6
MILLION IN
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES, SUFFICIENT TO
FUND OPERATIONS INTO 2026
Source text for Eikon: ID:nGNX9d1bl6
Further company coverage: TNGX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,